Companies / Pelthos Therapeutics Inc.

Pelthos Therapeutics Inc.

NYSE: PTHSCIK 1919246DURHAM, NC
Insider flow · last 90 daysNet buys $1000.0K

Financials · FY2025

Revenue$16.80M
Net income$-43.32M
Total debt—
Cash$24.19M
Diluted EPS$-23.04
Shares outstanding3.8M

Ownership

3.8M shares outstanding · as of Aug 10, 2026
2.6%Insiders
Ownership
Insiders2.63%100,515
Institutions32.69%1,251,679
Public float64.68%2,476,275

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insider% of sharesShares
Davis Todd CDirector
1.98%75,834
0.64%24,681

Institutional holders 18

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 11, 2026Davis Todd C
Director
BuyCommon Stock$985.5K+35K
+88.87%
75,331
1.97% of shares
high
Jun 11, 2026Davis Todd C
Director
BuyCommon Stock$14.4K+503
+0.67%
75,834
1.98% of shares
low
Apr 2, 2026Greenleaf Peter
Director
SellCommon Stock$8.6K-420
-1.65%
25,058
0.65% of shares
low
Apr 2, 2026Greenleaf Peter
Director
SellCommon Stock$8.1K-377
-1.50%
24,681
0.64% of shares
low
Jul 2, 2025Davis Todd C
Director
GrantCommon Stock$0+19K
+91.96%
39,886
1.04% of shares
low
Nov 13, 2024Davis Todd C
Director
GrantCommon Stock$0+5K
+31.36%
20,778
0.54% of shares
low
Jun 14, 2024Davis Todd C
Director
GrantCommon Stock$0+13K
+442.24%
15,817
0.41% of shares
low
Jul 2, 2025Greenleaf Peter
Director
GrantCommon Stock$0+25K
25,478
0.67% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Ikarian Capital, LLCPassive13G/A———
3i, LPPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
PTHSCommon StockEquity171126204BBG01C9YP5V5